Literature DB >> 30305726

Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment.

Sandra Muñoz-Galván1,2, Antonio Lucena-Cacace1,2, Marco Perez1,2, Daniel Otero-Albiol1,2, Julian Gomez-Cambronero3, Amancio Carnero4,5.   

Abstract

Cancer cells are in continuous communication with the surrounding microenvironment and this communication can affect tumor evolution. In this work, we show that phospholipase D2 (PLD2) was overexpressed in colon tumors and is secreted by cancer cells, inducing senescence in neighboring fibroblasts. This occurs through its lipase domain. Senescence induced by its product, phosphatidic acid, leads to a senescence-associated secretory phenotype (SASP) able to increase the stem properties of cancer cells. This increase in stemness occurs by Wnt pathway activacion. This closes a feedback loop in which senescence acts as a crosspoint for the generation of CSCs mediated by phospholipid metabolism. We also demonstrate the connexion of both phenomena in mouse models in vivo showing that a high PLD2 expression increased stemness and tumorigenesis. Thus, the patients with colon cancer show high levels of PLD2 and SASP factor genes expression correlating with Wnt pathway activation. Therefore, we demonstrate that tumor cell-secreted PLD2 contributes to tumor development by modifying the microenvironment, making it a possible therapeutic target for cancer treatment. This mechanism may also explain the high levels of Wnt pathway activation in colon cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30305726     DOI: 10.1038/s41388-018-0527-2

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   8.756


  52 in total

1.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

2.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.

Authors:  Louis Vermeulen; Felipe De Sousa E Melo; Maartje van der Heijden; Kate Cameron; Joan H de Jong; Tijana Borovski; Jurriaan B Tuynman; Matilde Todaro; Christian Merz; Hans Rodermond; Martin R Sprick; Kristel Kemper; Dick J Richel; Giorgio Stassi; Jan Paul Medema
Journal:  Nat Cell Biol       Date:  2010-04-25       Impact factor: 28.824

3.  BRAFE600-associated senescence-like cell cycle arrest of human naevi.

Authors:  Chrysiis Michaloglou; Liesbeth C W Vredeveld; Maria S Soengas; Christophe Denoyelle; Thomas Kuilman; Chantal M A M van der Horst; Donné M Majoor; Jerry W Shay; Wolter J Mooi; Daniel S Peeper
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

4.  Tumour biology: senescence in premalignant tumours.

Authors:  Manuel Collado; Jesús Gil; Alejo Efeyan; Carmen Guerra; Alberto J Schuhmacher; Marta Barradas; Alberto Benguría; Angel Zaballos; Juana M Flores; Mariano Barbacid; David Beach; Manuel Serrano
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

5.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.

Authors:  Zhenbang Chen; Lloyd C Trotman; David Shaffer; Hui-Kuan Lin; Zohar A Dotan; Masaru Niki; Jason A Koutcher; Howard I Scher; Thomas Ludwig; William Gerald; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

6.  Oncogene-induced senescence as an initial barrier in lymphoma development.

Authors:  Melanie Braig; Soyoung Lee; Christoph Loddenkemper; Cornelia Rudolph; Antoine H F M Peters; Brigitte Schlegelberger; Harald Stein; Bernd Dörken; Thomas Jenuwein; Clemens A Schmitt
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

8.  Senescence of human fibroblasts induced by oncogenic Raf.

Authors:  J Zhu; D Woods; M McMahon; J M Bishop
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 10.  Cancer stem cell definitions and terminology: the devil is in the details.

Authors:  Peter Valent; Dominique Bonnet; Ruggero De Maria; Tsvee Lapidot; Mhairi Copland; Junia V Melo; Christine Chomienne; Fumihiko Ishikawa; Jan Jacob Schuringa; Giorgio Stassi; Brian Huntly; Harald Herrmann; Jean Soulier; Alexander Roesch; Gerrit Jan Schuurhuis; Stefan Wöhrer; Michel Arock; Johannes Zuber; Sabine Cerny-Reiterer; Hans E Johnsen; Michael Andreeff; Connie Eaves
Journal:  Nat Rev Cancer       Date:  2012-10-11       Impact factor: 60.716

View more
  15 in total

1.  NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer.

Authors:  Timothy Nacarelli; Takeshi Fukumoto; Joseph A Zundell; Nail Fatkhutdinov; Stephanie Jean; Mark G Cadungog; Mark E Borowsky; Rugang Zhang
Journal:  Cancer Res       Date:  2019-12-19       Impact factor: 12.701

2.  PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.

Authors:  Sandra Muñoz-Galván; Maria Rivero; Javier Peinado-Serrano; Julia Martinez-Pérez; M C Fernández-Fernández; María José Ortiz; José M García-Heredia; Amancio Carnero
Journal:  Cells       Date:  2020-04-25       Impact factor: 6.600

3.  ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells.

Authors:  Tianhui Pan; Jingwen Liu; Song Xu; Qiao Yu; Hongping Wang; Hongxiang Sun; Jia Wu; Yue Zhu; Jianwei Zhou; Yongliang Zhu
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

4.  Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.

Authors:  Sandra Muñoz-Galván; Blanca Felipe-Abrio; Eva M Verdugo-Sivianes; Marco Perez; Manuel P Jiménez-García; Elisa Suarez-Martinez; Purificacion Estevez-Garcia; Amancio Carnero
Journal:  Mol Cancer       Date:  2020-01-11       Impact factor: 27.401

5.  A secretory phospholipase D hydrolyzes phosphatidylcholine to suppress rice heading time.

Authors:  Li Qu; Yu-Jia Chu; Wen-Hui Lin; Hong-Wei Xue
Journal:  PLoS Genet       Date:  2021-12-08       Impact factor: 5.917

6.  Upregulated phospholipase D2 expression and activity is related to the metastatic properties of melanoma.

Authors:  Arantza Perez-Valle; Begoña Ochoa; Krushangi N Shah; Gabriel Barreda-Gomez; Egoitz Astigarraga; María Dolores Boyano; Aintzane Asumendi
Journal:  Oncol Lett       Date:  2022-03-09       Impact factor: 2.967

Review 7.  Advances in NAD-Lowering Agents for Cancer Treatment.

Authors:  Moustafa S Ghanem; Fiammetta Monacelli; Alessio Nencioni
Journal:  Nutrients       Date:  2021-05-14       Impact factor: 5.717

8.  Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7.

Authors:  Mustafa Karabicici; Sena Alptekin; Zeynep Fırtına Karagonlar; Esra Erdal
Journal:  Mol Oncol       Date:  2021-03-08       Impact factor: 6.603

Review 9.  From cancer to rejuvenation: incomplete regeneration as the missing link (part II: rejuvenation circle).

Authors:  Mamuka G Baramiya; Eugene Baranov; Irina Saburina; Lev Salnikov
Journal:  Future Sci OA       Date:  2020-06-30

Review 10.  Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.

Authors:  Sandra Muñoz-Galván; Amancio Carnero
Journal:  Cells       Date:  2020-06-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.